MyHunch: In the article that you posted "In September, the U.S. government gave Sanofi Aventis' (NYSE:SNY - News) vaccine unit a $97 million, five-year contract to produce a mammalian, cell-based flu vaccine."
CRXL is the one that licenses its cell-based technology to Sanofi Aventis for flu vac production. I believe CRXL will have a great potential even though it has tremendous run this yr.
How many people will the bug kill? Can it be contained? What vaccine will work, if any? How strong must the vaccine be? How many doses? Who will make it? How fast?
And what about Betty Lou?
So.......serious question........who do ya think is goin to the Superbowl?<g>